The epidemiology of prolactinomas

Pituitary

Volumn 8, Issue 1, 2005, Pages 3-6

  Ciccarelli, Antonio ^a   Daly, Adrian F ^a   Beckers, Albert ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Epidemiology; Inherited; Neoplasm; Pituitary; Prolactin; Prolactinoma; Tumor

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CHLORPROMAZINE; CIMETIDINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOMPERIDONE; DOPAMINE; ESTROGEN; FLUPHENAZINE; GROWTH HORMONE; HALOPERIDOL; IMIPRAMINE; METHIONINE; METHYLDOPA; METOCLOPRAMIDE; OPIATE; PERPHENAZINE; PROLACTIN; PROMAZINE; RESERPINE; SULPIRIDE; TRIFLUOPERAZINE; VERAPAMIL;

AGE; ALBRIGHT SYNDROME; ARTICLE; CANCER RECURRENCE; CARNEY COMPLEX; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMORBIDITY; EPIDEMIOLOGICAL DATA; FAMILY STUDY; GENE MUTATION; GROWTH DISORDER; GROWTH HORMONE RELEASE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; INCIDENCE; INHERITANCE; LIVER CIRRHOSIS; MEDICAL LITERATURE; MENTAL STRESS; MULTIPLE ENDOCRINE NEOPLASIA; PHYSICAL STRESS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; SEX RATIO; VISUAL DISORDER; ADOLESCENT; ADULT; CHILD; FEMALE; GENETICS; HYPOPHYSIS TUMOR; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY NEOPLASMS; PREVALENCE; PROLACTINOMA; SEX FACTORS;

EID: 33644867558     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-5079-0     Document Type: Article

References (34)

1. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981; 304 (3): 156-158.
2. Molitch ME, Russell EJ. The pituitary incidentaloma. Ann Intern Med 1990; 112 (12): 925-931.
3. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: Occult adenomas in the general population. Ann Intern Med 1994; 120 (10): 817-820.
4. Colao A, Lombardi G. Growth-hormone and prolactin excess. Lancet 1998; 352: 1455-1461.
5. Vance ML, Thorner MO. Prolactin: Hyperprolactinemic syndromes and management. In: DeGroot LJ, ed. Textbook of Endocrinology, 2nd edition. Philadelphia, London, Toronto, Mexico City, Rio de Janerio, Sydney, Tokyo, Hong Kong:WB Saunders Company 1989; 408-418.
6. Arafah BM, Nasrallah MP. Pituitary tumors. pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001; 8 (4): 287-305.
7. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994; 41 (3): 359-364.
8. Davis JR, Farrell WE, Clayton RN. Pituitary tumours. Reproduction 2001; 121 (3): 363-371.
9. Beckers A, Adam C, Ciccarelli A, Rixhon M, Daly A, Petrossians P, Stevenaert A. Approaching the true prevalence of pituitary tumors. ENEA Congress 2004; Abstract O1.1: 23. www.eneassoc.org/abstracts.pdf (accessed October 28th, 2005).
10. Calle-Rodriguez RD, Giannini C, Scheithauer BW et al. Prolactinomas in male and female patients: A comparative clinicopathologic study. Mayo Clin Proc 1998; 73: 1046-1052.
11. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J. Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997; 82: 2102-2107.
12. Kovacs K, Ryan N, Horvath E, Singer W, Ezrin C. Pituitary adenomas in old age. J Gerontol 1980; 35 (1): 16-22.
13. McComb DJ, Ryan N, Horvath E, Kovacs K. Subclinical adenomas of the human pituitary. New light on old problems. Arch Pathol Lab Med 1983; 107 (9): 488-491.
14. Cohen DL, Bevan JS, Adams CB. The presentation and management of pituitary tumours in the elderly. Age Ageing 1989; 18 (4): 247-252.
15. Benbow SJ, Foy P, Jones B, Shaw D, McFarlane IA. Pituitary tumors presenting in the elderly: Management and outcome. Clin Endocrinol 1997; 46: 657-660.
16. Turner HE, Christopher BTA, Wass JAH. Pituitary tumors in the elderly: A 20 year experience. Eur J Endocrinol 1999; 140: 383-389.
17. Mindermann T, Wilson CB. Pituitary adenomas in childhood and adolescence. J Pediatr Endocrinol Metab 1995; 8: 79-83.
18. Colao A, Loche S, Cappa M et al. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 1998; 83: 2777-2780.
19. Lafferty AR, Chrousos GP. Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 1999; 84: 4317-4323.
20. Obuobie K, Mullik V, Jones C et al. McCune-Albright Syndrome: Growth hormone dynamics in pregnancy. J Clin Endocrinol Metab 2001; 86: 2456-2458.
21. Bhansali A, Sharma BS, Sreenivasulu P, Singh P, Vashisth RK, Dash RJ. Acromegaly with fibrous dysplasia: McCune-Albright syndrome. Endocrine J 2003; 50: 793-799.
22. Petrossians P, De Herder W, Kwekkeboom D, Lamberigts G, Stevenaert A, Beckers A. Malignant Prolactinoma discovered by D2 receptor imaging. J Clin Endocrinol Metab 2000; 85 (1): 398-401.
23. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86 (12): 5658-5671.
24. Verges B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002; 87 (2): 457-465.
25. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: Clinical features and inheritance pattern. J Clin Endocrinol Metab 1996; 81 (5): 1841-1845.
26. Knudson AG. Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 1996; 122 (3): 135-140.
27. Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: Clinical and genetic characteristics of 36 kindreds. Medicine 2002; 81 (1): 1-26.
28. Hao W, Skarulis MC, Simonds WF, et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 2004; 89 (8): 3776-3784.
29. Petty EM, Green JS, Marx SJ, Taggart RT, Farid N, Bale AE. Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: Evidence for a founder effect in patients from Newfoundland. Am J Hum Genet 1994; 54 (6): 1060-1066.
30. Olufemi SE, Green JS, Manickam P, et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 1998; 11 (4): 264-269.
31. Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001; 86 (9): 4041-4046.
32. Berezin M, Karasik A. Familial Prolactinoma. Clinical Endocrinology 1995; 42: 483-486.
33. Poncin J, Abs R, Velkeniers B, et al. Mutation analysis of the MEN1 gene in Belgian patients with Multiple Neoplasia Type 1 and related diseases. Hum Mutation 1999; 13: 54-60.
34. Daly AF, Jaffrain-Rea ML, Beckers A. Clinical and genetic features of familial pituitary adenomas. Horm Metab Res 2005; 37 (6): 347-354.